2009
DOI: 10.1016/j.ahj.2009.07.029
|View full text |Cite
|
Sign up to set email alerts
|

Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: A comparison of two strategies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
5
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 27 publications
1
5
0
Order By: Relevance
“…However, this benefit was driven mainly by periprocedural myocardial infarction, a controversial end point. Of importance, similar trends were observed in elective PCI in that 15% to 40% of NSTE-ACS patients were stabilized [27][28][29] ( Figure 2B). One may argue that the lack of mortality benefit in this patient subset is a concern.…”
supporting
confidence: 55%
“…However, this benefit was driven mainly by periprocedural myocardial infarction, a controversial end point. Of importance, similar trends were observed in elective PCI in that 15% to 40% of NSTE-ACS patients were stabilized [27][28][29] ( Figure 2B). One may argue that the lack of mortality benefit in this patient subset is a concern.…”
supporting
confidence: 55%
“…On the other hand, in patients with stable CAD who are scheduled for PCI, the pathophysiology of disease is completely different, CV risk is low, and peri-procedural ischemic events are much less frequent than in ACS. Indeed, most studies on pre-treatment of stable CAD patients have failed to show a clear signal of benefit (10,(15)(16)(17)(18)(19)(20)(21)(22)(23) (Table 1). Consistently, the most recent guidelines issued by the…”
Section: Pre-treatment In Stable Versus Unstable Patients: Two Differmentioning
confidence: 99%
“…Post-PCI hsCRP levels significantly decreased with the addition of eptifibatide, implying that antiplatelet therapy with clopidogrel alone was not sufficient to overcome the inflammatory response. In the ARMYDA-2 study, hsCRP levels also increased post-PCI with no difference in the 24 h levels between patients loaded 4-8 h before PCI with 300 vs 600 mg of clopidogrel [14], while a similar increase was described in clopidogrel naive patients loaded with 900 mg of clopidogrel and undergoing PCI either immediately or 2 h later [26]. Therefore, although clopidogrel pretreatment reduces hsCRP post-PCI compared to no pretreatment, it does not seem to be any further benefit with higher loading dose, or with administration of the loading dose 2-8 h before the procedure.…”
Section: Clopidogrel Loading and Inflammationmentioning
confidence: 60%
“…unstable patients) without however direct evidence that delaying PCI for 2 h -as suggested by the guidelines -is not necessary and that ad hoc PCI is safe. The strategy of 2 h delay in performing PCI after loading with the patient monitored in the recovery room of the catheterization laboratory was tested recently by our group [26], where we found no difference in clinical end points at 30 days between delaying PCI for 2 h vs immediate PCI after loading. Studies with outcome of PCI patients loaded in the catheterization laboratory immediately prior to intervention are shown in Table 2.…”
Section: Timing Of Administrationmentioning
confidence: 96%